WebRCT Industry News


TMCNet:  Downgrade Alert for Salix Pharmaceuticals (SLXP)

[May 10, 2013]

Downgrade Alert for Salix Pharmaceuticals (SLXP)

May 10, 2013 (SmarTrend(R) Upgrades/Downgrades via COMTEX) -- Salix Pharmaceuticals (NASDAQ:SLXP) was downgraded from Buy to Neutral at Janney Montgomery today. The stock closed yesterday at $54.35 on volume of 323,000 shares, below average daily volume of 512,000. Salix Pharmaceuticals has overhead space with shares priced $54.16, or 2.4% below the average consensus analyst price target of $55.50. Salix Pharmaceuticals shares have support at the 50-day moving average (MA) of $50.40 and additional support at the 200-day MA of $45.47.


Salix Pharmaceuticals, Ltd. develops and markets prescription pharmaceutical products for the treatment of gastrointestinal diseases. The Company's COLAZAL product is an anti-inflammatory drug used for the treatment of mildly to moderately active ulcerative colitis.

In the past 52 weeks, Salix Pharmaceuticals share prices have been bracketed by a low of $37.52 and a high of $55.99 and closed yesterday at $54.16, 44% above that low price. Over the past week, the 200-day moving average (MA) has remained constant while the 50-day MA has advanced 0.9%.

SmarTrend recommended that subscribers consider buying shares of Salix Pharmaceuticals on December 5th, 2012 as our proprietary SmarTrend analytics indicated a new Uptrend was in progress when shares hit $42.64. Since that recommendation, shares of Salix Pharmaceuticals have risen 27.0%. We continue to monitor SLXP for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.

Write to Chip Brian at cbrian@mysmartrend.com --------------------------------------------------------------------------------------------- SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.MySmarTrend.com Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.MySmarTrend.com/signup

[ Back To Homepage ]

Stay Connected with WebRTC World

Free WebRTC eNewsletter

Sign up now to recieve your free WebRTC eNewsletter for all up to date news and conference details. Its free! what are you waiting for.

Featured Videos